Results 121 to 130 of about 9,985 (145)

Higher clearance of micafungin in neonates compared with adults: role of age‐dependent micafungin serum binding

open access: yesBiopharmaceutics and Drug Disposition, 2011
Micafungin, a new echinocandin antifungal agent, has been widely used for the treatment of various fungal infections in human populations. Micafungin is predominantly cleared by biliary excretion and it binds extensively to plasma proteins (>99.5 ...
Daniel K Benjamin   +2 more
exaly   +3 more sources

Micafungin for the treatment of invasive aspergillosis

open access: yesJournal of Infection, 2014
Invasive aspergillosis is a major cause of morbidity and mortality in immunocompromised patients, particularly those with neutropenia and those undergoing bone marrow or stem cell transplants.
D A Enoch, S H Aliyu, J A Karas
exaly   +2 more sources

Micafungin Inhibits Dengue Virus Infection through the Disruption of Virus Binding, Entry, and Stability

open access: yesPharmaceuticals, 2021
Dengue fever is an arbovirus disease caused by infection with the dengue virus (DENV). Half of the world’s population lives under the threat of dengue fever, however, researchers have yet to develop any drugs that are clinically applicable to this ...
Yen-Chen Chen   +2 more
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Micafungine

Journal de Mycologie Médicale, 2010
openaire   +1 more source

Micafungin

Reactions Weekly, 2006
openaire   +2 more sources

In Vitro Exposure to Increasing Micafungin Concentrations Easily Promotes Echinocandin Resistance in Candida glabrata Isolates

Antimicrobial Agents and Chemotherapy, 2017
Pilar Escribano   +2 more
exaly  

Home - About - Disclaimer - Privacy